Filing metadata

Accession number
0001127602-21-022943
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Aug 03, 2021
Reporting period
Aug 02, 2021
Description
Insider transaction

Explore SEC Filings Hub